To conclude, we have demonstrated for the first time the consequences of aberrant KLK6 expression in colon cancer derived cell lines and its link to PAR2 receptor signaling, leading to significant ERK1/2 phosphorylation and cell proliferation, presumably by activating PAR2. This evidence concerns the gene KLK6 and colonic neoplasm.